Vector U loop in patients with idiopathic cardiomyopathy

T Fujimoto1, K Kiyoshige, Y Saito

  • 1Second Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.

Insights

The U loop in vectorcardiograms is larger in hypertrophic cardiomyopathy, particularly apical hypertrophy, and shifts anteriorly/rightward in both hypertrophic and dilated cardiomyopathy, correlating with posterior wall thickness.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Vectorcardiography (VCG) provides unique spatial insights into cardiac electrical activity.
  • The U loop in VCG, representing late ventricular repolarization, has not been fully characterized in various cardiomyopathies.
  • Understanding U loop characteristics may offer diagnostic markers for myocardial disease.

Purpose of the Study:

  • To investigate the spatial characteristics of the U loop in patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
  • To correlate U loop findings with echocardiographic parameters, particularly left ventricular wall thickness.
  • To determine if U loop alterations can differentiate between HCM subtypes and DCM.

Main Methods:

  • Recorded U loops from vectorcardiograms in 50 normal subjects, 10 DCM patients, and 83 HCM patients (including obstructive HCM, nonobstructive HCM, and apical hypertrophy subgroups).
  • Analyzed U loop spatial characteristics qualitatively and quantitatively.
  • Correlated U loop parameters with echocardiographic measurements of left ventricular hypertrophy.

Main Results:

  • U loop magnitude was significantly increased in the HCM group (especially apical hypertrophy) compared to controls, but not in the DCM group.
  • The maximum U vector showed significant anterior and rightward displacement in both DCM and HCM groups, most pronounced in apical hypertrophy and nonobstructive HCM.
  • U loop magnitude correlated with posterior left ventricular wall thickness in nonobstructive HCM and apical hypertrophy subgroups.

Conclusions:

  • The U loop is significantly altered in hypertrophic cardiomyopathy, reflecting hypertrophy of the left ventricular apex and posterior wall.
  • U loop spatial displacement is observed in both hypertrophic and dilated cardiomyopathies.
  • U loop analysis may serve as a valuable tool for assessing myocardial structural changes in cardiomyopathies.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...